2025 annual financial data
INmune Bio 2025 Operating margin
INmune Bio 2025 operating margin with verified reported values.
Direct answer
Operating margin was -61,738%.
Operating income was -30,869,000 USD and net income was -45,933,000 USD.
Operating cash flow was -22,582,000 USD.
Get free INmune Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 50,000 USD
- Operating income
- -30,869,000 USD
- Net income
- -45,933,000 USD
- Operating cash flow
- -22,582,000 USD